Bristol-Myers Squibb (BMY) Misses Q1 EPS by 7c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $66.81 +0.35%
Financial Fact:
Provision for income taxes: 344M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Financial Fact:
Provision for income taxes: 344M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.74, $0.07 worse than the analyst estimate of $1.81. Revenue for the quarter came in at $11.1 billion versus the consensus estimate of $11.11 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2021 EPS of $7.35-$7.55, versus the consensus of $7.48.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
- Herbalife reaffirms Q3 and full-year 2026 financial guidance
- Goldman Sachs Upgrades Drax Group Plc. (DRX:LN) (DRXGY) to Buy
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
